Clinical trials
Recruiting Fallopian Tube Neoplasms trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 11 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AbbVie | 1 |
| Artios Pharma Ltd | 1 |
| AstraZeneca | 1 |
| Daiichi Sankyo | 1 |
| Eli Lilly and Company | 1 |
| Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. | 1 |
| Fore Biotherapeutics | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Regeneron Pharmaceuticals | 1 |
| Royal Surrey County Hospital NHS Foundation Trust | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fallopian Tube Neoplasms | 11 |
| Ovarian Neoplasms | 9 |
| Breast Neoplasms | 2 |
| Endometrial Neoplasms | 2 |
| Glioma | 2 |
| Neoplasm Metastasis | 2 |
| Astrocytoma | 1 |
| Biliary Tract Neoplasms | 1 |
| Carcinoma, Acinar Cell | 1 |
| Carcinoma, Endometrioid | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.